← FDA DRUG APPROVALS

FDA ANDA · ANDA208011

AZELAIC ACID

Sponsor: ACTAVIS LABS UT INC

APPLICATION
ANDA208011
TYPE
ANDA
ORIGINAL APPROVAL
2018-11-19
LATEST ACTION
2024-03-06
ROUTE
TOPICAL
DOSAGE FORM
GEL
MARKETING STATUS
Prescription

Products

AZELAIC ACIDPrescription
AZELAIC ACID 15% · GEL · TOPICAL

Approval history

2024-03-06Labeling · Supplement 3 · standardAP
2024-03-06Labeling · Supplement 4 · standardAP
2018-11-19UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →